|
⚲
|
| Keyboard |
| El-Hibri Fuad
✚
|
|
|---|---|
| CIK # | 0001380185 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001380185] | |
| 4 | [0001380185] | |
| SC 13D | [0001380185] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| El-Hibri FUAD | Aptevo Therapeutics Inc | [2016-08-03] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aptevo Therapeutics Inc | |
| El-Hibri Fuad | |
| Emergent BioSolutions Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Emergent BioSolutions Inc EBS
Common Stock
|
2021-12-03 | Other | 206,434 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2021-12-03 | Other | 3,018,644 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2021-12-03 | Other | 274,930 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2021-12-03 | Other | 9,819 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2021-12-03 | Other | 7,373 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2021-12-03 | Other | 107,807 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Stock Option (right to buy) · derivative
|
2021-06-01 | Grant | 2,678 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2021-06-01 | Grant | 893 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Employee Stock Options (Right to Buy) · derivative
|
2021-02-24 | Grant | 27,808 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Restricted Stock Unit · derivative
|
2021-02-24 | Grant | 13,906 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Stock Options (Right to Buy) · derivative
|
2020-11-10 | Option exercise | 19,391 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-10 | Sell | 19,391 | $88.21 | 1,710,480 |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-10 | Option exercise | 19,391 | $26.45 | 512,892 |
|
Emergent BioSolutions Inc EBS
Stock Options (Right to Buy) · derivative
|
2020-11-09 | Option exercise | 20,000 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-09 | Option exercise | 20,000 | $26.45 | 529,000 |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-09 | Sell | 20,000 | $95.26 | 1,905,200 |
|
Emergent BioSolutions Inc EBS
Stock Options (Right to Buy) · derivative
|
2020-11-03 | Option exercise | 20,000 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-03 | Option exercise | 20,000 | $26.45 | 529,000 |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-03 | Sell | 20,000 | $90.74 | 1,814,800 |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2020-11-02 | Option exercise | 20,000 | $26.45 | 529,000 |
| showing 20 of 200 most recent transactions | |||||